Future Medicine India – Regulations & Polices Regulations and Policies Archives | Future Medicine India

Regulations and Policies

Centre moves to integrate allopathy with AYUSH: IMA sees red

With the union government moving ahead with its plan to integrate all systems of medicine, the Indian Medical Association (IMA), the largest body of allopathic practitioners in the country, is planning to oppose the move tooth and nail.

FM
Read More..

Digital Health Mission in the crosshairs

Even as National Digital Health Mission (NDHM) envisions a unique personal health ID for every Indian citizen, digitized health records and a national registry of doctors and health facilities, Indian Medical Association (IMA) has expressed strong reservations over National Digital Health Blueprint (NDHB) published recently.

FM

Allopaths oppose combining modern and AYUSH systems

New Education Policy (NEP), approved by the central government recently, proposes a complete overhaul of the country’s education system.

FM

Epidemic Diseases (Amendment) Ordinance, 2020: Healthcare professionals laud central law

The central government has brought an ordinance for the protection of healthcare professionals amid reports of attacks on doctors, nurses and other healthcare personnel treating COVID-19 patients.

FM

Kerala brings community-centric palliative care 

Aimed at ensuring access to effective and good quality palliative care services for every person in the state, the Kerala government recently introduced revised pain and palliative care policy with a focus on home-based care.

FM

Surrogacy Bill: Violators face up to 5 years jail term; 10 lakhs fine

The Lok Sabha, the lower house of the Indian parliament, has cleared The Surrogacy (Regulation) Bill, 2019, recently. The bill prohibits commercial surrogacy and allows “altruistic surrogacy” which does not involve monetary compensation to the surrogate mother apart from medical expenses and insurance coverage during the pregnancy. One of the major aims of the bill […]

FM

EMA & USFDA: On the same page?

EMA and the US Food and Drug Administration (FDA) are aligned in more than 90% of marketing authorisation decisions for new medicines, found a joint analysis by the top global drug regulatory agencies.   The EMA/FDA analysis compared decisions on 107 new medicine applications at the two agencies between 2014 and 2016. The study entitled […]

FM